Becker's Healthcare November 10, 2021
The COVID-19 pandemic has accelerated the adoption of digital health for about 20 months, but the FDA’s health IT agenda has remained largely untouched, Politico reported Nov. 10.
Five things to know:
- The FDA is facing several questions on the future of medical software and how this technology plays a role in telehealth and clinical decision-making moving forward, Politico reported.
- At the start of the pandemic, the FDA relaxed regulations on products that helped deliver virtual care. Yet once the public health emergency comes to an end, there isn’t a clear path as to what happens with these technologies, according to the report.
- The health IT industry is also looking for signs from the FDA on how...